BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 25980571)

  • 1. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.
    Witman MA; Garten RS; Gifford JR; Groot HJ; Trinity JD; Stehlik J; Nativi JN; Selzman CH; Drakos SG; Richardson RS
    JACC Heart Fail; 2015 Sep; 3(9):703-11. PubMed ID: 26277768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
    Khan T; Levin HR; Oz MC; Katz SD
    J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of left ventricle assist device on circulating endothelial microparticles - pilot study.
    Pitha J; Dorazilova Z; Melenovsky V; Kralova Lesna I; Stavek P; Stepankova J; Urban M; Maly J; Netuka I
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():68-72. PubMed ID: 23183513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous flow left ventricular assist device support on microvascular endothelial function.
    Lou X; Templeton DL; John R; Dengel DR
    J Cardiovasc Transl Res; 2012 Jun; 5(3):345-50. PubMed ID: 21932132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved endothelial function and decreased levels of endothelium-derived microparticles after transcatheter aortic valve implantation.
    Horn P; Stern D; Veulemans V; Heiss C; Zeus T; Merx MW; Kelm M; Westenfeld R
    EuroIntervention; 2015 Apr; 10(12):1456-63. PubMed ID: 25287265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does third generation left ventricular assist device alter heart failure-related microvascular dysfunction?
    Esmaeilzadeh F; Dendievel R; Wauters A; Vachiery JL; Van Nooten G; Van De Borne P; Argacha JF
    Acta Cardiol; 2016 Aug; 71(4):403-10. PubMed ID: 27594355
    [No Abstract]   [Full Text] [Related]  

  • 9. Biphasic response in number of stem cells and endothelial progenitor cells after left ventricular assist device implantation: A 6month follow-up.
    Ivak P; Pitha J; Wohlfahrt P; Kralova Lesna I; Stavek P; Melenovsky V; Dorazilova Z; Hegarova M; Stepankova J; Maly J; Sekerkova A; Turcani D; Netuka I
    Int J Cardiol; 2016 Sep; 218():98-103. PubMed ID: 27232919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant impact of left ventricular assist device models on the value of flow-mediated dilation: effects of LVAD on endothelial function.
    Watanabe A; Amiya E; Hatano M; Watanabe M; Ozeki A; Nitta D; Maki H; Hosoya Y; Tsuji M; Bujo C; Saito A; Endo M; Kagami Y; Nemoto M; Nawata K; Kinoshita O; Kimura M; Ono M; Komuro I
    Heart Vessels; 2020 Feb; 35(2):207-213. PubMed ID: 31327031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Function in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Poredos P; Jezovnik MK; Radovancevic R; Gregoric ID
    Angiology; 2021 Jan; 72(1):9-15. PubMed ID: 32757767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of endothelial microparticles in patients with arterial hypertension, hypertensive emergencies and catheter-related injury.
    Sansone R; Baaken M; Horn P; Schuler D; Westenfeld R; Amabile N; Kelm M; Heiss C
    Atherosclerosis; 2018 Jun; 273():67-74. PubMed ID: 29684662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction.
    Maréchaux S; Samson R; van Belle E; Breyne J; de Monte J; Dédrie C; Chebai N; Menet A; Banfi C; Bouabdallaoui N; Le Jemtel TH; Ennezat PV
    J Card Fail; 2016 Jan; 22(1):3-11. PubMed ID: 26386451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices.
    Nascimbene A; Hernandez R; George JK; Parker A; Bergeron AL; Pradhan S; Vijayan KV; Civitello A; Simpson L; Nawrot M; Lee VV; Mallidi HR; Delgado RM; Dong JF; Frazier OH
    J Heart Lung Transplant; 2014 May; 33(5):470-7. PubMed ID: 24656391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.